Lipella Pharmaceuticals Inc. (LIPO)
NASDAQ: LIPO · IEX Real-Time Price · USD
0.720
0.00 (0.00%)
Mar 28, 2024, 2:12 PM EDT - Market open

Lipella Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020
Revenue
0.450.180.260.96
Revenue Growth (YoY)
144.15%-28.99%-73.03%-
Gross Profit
0.450.180.260.96
Selling, General & Admin
2.160.230.720.04
Research & Development
3.042.551.460.98
Operating Expenses
5.22.772.181.02
Operating Income
-4.75-2.59-1.92-0.06
Interest Expense / Income
0.010.010.010.01
Other Expense / Income
-0.14-0-0.06-0
Pretax Income
-4.62-2.6-1.87-0.06
Net Income
-4.62-2.6-1.87-0.06
Shares Outstanding (Basic)
6435
Shares Outstanding (Diluted)
6435
Shares Change
47.84%19.15%-36.04%-
EPS (Basic)
-0.77-0.64-0.55-0.01
EPS (Diluted)
-0.77-0.64-0.55-0.01
Free Cash Flow
-3.16-1.83-0.99-0.03
Free Cash Flow Per Share
-0.53-0.45-0.29-0.01
Gross Margin
100.00%100.00%100.00%100.00%
Operating Margin
-1055.55%-1406.26%-738.71%-5.91%
Profit Margin
-1027.31%-1410.59%-719.30%-6.41%
Free Cash Flow Margin
-703.84%-994.35%-381.45%-2.97%
EBITDA
-4.61-2.59-1.86-0.05
EBITDA Margin
-1024.52%-1405.37%-716.66%-5.58%
Depreciation & Amortization
0000
EBIT
-4.61-2.59-1.86-0.05
EBIT Margin
-1024.90%-1405.37%-716.66%-5.58%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).